Cyclerion Therapeutics (CYCN) Assets (2018 - 2025)

Cyclerion Therapeutics has reported Assets for 8 years, with the latest figure at $10.0 million in Q4 2025.

• On a quarterly basis, Assets rose 4.28% year-over-year to $10.0 million in Q4 2025; TTM through Dec 2025 was $10.0 million, a 4.28% increase from a year earlier, with the FY2025 full-year figure at $10.0 million, up 4.28% from the prior year.
• Assets was $10.0 million for Q4 2025 at Cyclerion Therapeutics, down from $10.4 million in the prior quarter.
• The five-year high for Assets was $100.0 million in Q1 2021, with the low at $8.9 million in Q3 2024.
• Average Assets over 5 years is $27.9 million, with a median of $12.4 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Assets slumped 75.38% in 2023, then advanced 17.05% in 2025.
• Over 5 years, Assets stood at $59.3 million in 2021, then sank by 69.53% to $18.1 million in 2022, then retreated by 26.02% to $13.4 million in 2023, then slipped by 28.41% to $9.6 million in 2024, then grew by 4.28% to $10.0 million in 2025.
• The last three Assets figures came in at $10.0 million (Q4 2025), $10.4 million (Q3 2025), and $9.4 million (Q2 2025), per Business Quant data.